Publications by authors named "Ana-Rosa Cid"

Claim this Profile
I
Impact of Family History of Haemophilia on Diagnosis, Management and Outcomes in Severe Haemophilia.
Ana Mendoza, Isabel Rivas, Olga Benítez Hidalgo, Ana Rosa Cid, Martin Olivieri

Haemophilia· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Type 2N VWD: Conclusions from the Spanish PCM-EVW-ES project.
Almudena Pérez-Rodríguez, Javier Batlle, Joana Costa Pinto, Irene Corrales, Nina Borràs, Ana Rosa Cid

Haemophilia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Challenges, questions and opportunities with regard to the new relationship between clinical practice and the haemostasis laboratory: the path towards personalized medicine.
Ana Rosa Cid

Blood Coagul Fibrinolysis· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical benefits of a Bayesian model for plasma-derived factor VIII/VWF after one year of pharmacokinetic-guided prophylaxis in severe/moderate hemophilia A patients.
Juan Eduardo Megías-Vericat, Santiago Bonanad, Saturnino Haya, Ana Rosa Cid, María Remedios Marqués

Thromb Res· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology.
Paolo Gresele, Emanuela Falcinelli, Loredana Bury, Alessandro Pecci, Marie-Christine Alessi, Ana Rosa Cid

J Thromb Haemost· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management.
Andrés Moret, Ángel Zúñiga, Javier Marco Ayala, Alessandro Liquori, Ana Rosa Cid

J Thromb Thrombolysis· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study.
Francesco Paciullo, Loredana Bury, Patrizia Noris, Emanuela Falcinelli, Federica Melazzini, Ana Rosa Cid

Haematologica· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC.
Paolo Gresele, Sara Orsini, Patrizia Noris, Emanuela Falcinelli, Marie Christine Alessi, Ana Rosa Cid

J Thromb Haemost· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort.
Nina Borràs, Iris Garcia-Martínez, Javier Batlle, Almudena Pérez-Rodríguez, Rafael Parra, Ana Rosa Cid

Thromb Haemost· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A.
Andreas Tiede, Ana Rosa Cid, Georg Goldmann, Victor Jiménez-Yuste, Michael Pluta

Thromb Haemost· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and molecular characterization by next generation sequencing of Spanish patients affected by congenital deficiencies of fibrinogen.
Andrés Moret, Ángel Zúñiga, Mariam Ibáñez, Ana Rosa Cid, Saturnino Haya

Thromb Res· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cross-sectional comparative study of pharmacokinetics and efficacy between sucrose-formulated recombinant factor VIII (Kogenate ) and BAY 81-8973 (Kovaltry ) in patients with severe or moderate haemophilia A in prophylaxis.
Juan Eduardo Megías-Vericat, Santiago Bonanad, Saturnino Haya, Ana Rosa Cid, María Remedios Marqués

Haemophilia· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unraveling the effect of silent, intronic and missense mutations on splicing: contribution of next generation sequencing in the study of mRNA.
Nina Borràs, Gerard Orriols, Javier Batlle, Almudena Pérez-Rodríguez, Teresa Fidalgo, Ana Rosa Cid

Haematologica· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive factors of immune tolerance treatment response in severe haemophilia A patients with inhibitors: A real-world report from a single centre, mixed retrospective-prospective long-term study.
Saturnino Haya, Carlos Solano, Ana Rosa Cid, Bienvenida Argilés, David Hervás

Haemophilia· March 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.
Almudena Pérez-Rodríguez, Javier Batlle, Irene Corrales, Nina Borràs, Ángela Rodríguez-Trillo, Ana Rosa Cid

PLoS One· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
α2-Macroglobulin Is a Significant In Vivo Inhibitor of Activated Protein C and Low APC:α2M Levels Are Associated with Venous Thromboembolism.
Laura Martos, Luis Andrés Ramón, Julia Oto, Álvaro Fernández-Pardo, Santiago Bonanad, Ana Rosa Cid

Thromb Haemost· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): comprehensive genetic analysis by next-generation sequencing of 480 patients.
Nina Borràs, Javier Batlle, Almudena Pérez-Rodríguez, María Fernanda López-Fernández, Ángela Rodríguez-Trillo, Ana Rosa Cid

Haematologica· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for the Progression from Low to High Titres in 260 Children with Severe Haemophilia A and Newly Developed Inhibitors.
Maria Elisa Mancuso, Kathelijn Fischer, Elena Santagostino, Johannes Oldenburg, Helen Platokouki, Ana Rosa Cid

Thromb Haemost· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders.
Sara Orsini, Patrizia Noris, Loredana Bury, Paula G Heller, Cristina Santoro, Ana Rosa Cid

Haematologica· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel mutations in RASGRP2, which encodes CalDAG-GEFI, abrogate Rap1 activation, causing platelet dysfunction.
María Luisa Lozano, Aaron Cook, José María Bastida, David S Paul, Gemma Iruin, Ana Rosa Cid

Blood· September 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A simplified assay for the quantification of circulating activated protein C.
Laura Martos, Santiago Bonanad, Luis A Ramón, Ana-Rosa Cid, Elena Bonet

Clin Chim Acta· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm.
Javier Batlle, Almudena Pérez-Rodríguez, Irene Corrales, Maria Fernanda López-Fernández, Ángela Rodríguez-Trillo, Ana Rosa Cid

Thromb Haemost· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional and molecular characterization of inherited platelet disorders in the Iberian Peninsula: results from a collaborative study.
Isabel Sánchez-Guiu, Ana I Antón, José Padilla, Francisco Velasco, José F Lucia, Ana Rosa Cid

Orphanet J Rare Dis· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First application of MLPA method in severe von Willebrand disease. Confirmation of a new large VWF gene deletion and identification of heterozygous carriers.
Noelia Cabrera, Pilar Casaña, Ana Rosa Cid, Andrés Moret, Manuel Moreno

Br J Haematol· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel missense mutation c.2685G>C (p.Q895H) in VWF gene associated with very low levels of VWF mRNA.
Noelia Cabrera, Pilar Casaña, Ana Rosa Cid, Saturnino Haya, Andrés Moret

Ann Hematol· March 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis